Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Mar;19(3):867–874. doi: 10.1128/iai.19.3.867-874.1978

Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans.

R Dolin, B R Murphy, E A Caplan
PMCID: PMC422269  PMID: 640733

Abstract

Virus-specific in vitro cell-mediated immune responses were investigated in 20 normal volunteers who were challenged with liver influenza A/VIC/3/75 (H3N2) virus and in 13 volunteers who were vaccinated with inactivated vaccine containing A/VIC and A/NJ/8/76 (HswN1) antigens. Lymphocyte cultures were established from peripheral blood samples obtained prior to and at various times after infection or vaccination. Blastogenesis was determined by [3H]thymidine incorporation after stimulation of cultures with purified, inactivated, whole influenza viruses. Six days after infection, significantly elevated levels of blastogenesis were observed after in vitro stimulation with A viruses of hemagglutinin and neuraminidase subtypes that were the same as (H3N2) or antigenically distinct from (Heq1Neq1 or HswN1) those of the challenge virus, although maximum stimulation was noted with virus of the same hemagglutinin subtype (H3) as the challenge virus. Similar although more prolonged blastogenic responses were noted in lymphocyte cultures from vaccinees who had serum antibody rises after vaccination. The kinetics of these responses suggest that cell-mediated immunity may play a role in early events after infection and vaccination with influenza virus.

Full text

PDF
867

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aymard-Henry M., Coleman M. T., Dowdle W. R., Laver W. G., Schild G. C., Webster R. G. Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ. 1973;48(2):199–202. [PMC free article] [PubMed] [Google Scholar]
  2. Bucher D. J., Li S. S., Kehoe J. M., Kilbourne E. D. Chromatographic isolation of the hemagglutinin polypeptides from influenza virus vaccine and determination of their amino-terminal sequences. Proc Natl Acad Sci U S A. 1976 Jan;73(1):238–242. doi: 10.1073/pnas.73.1.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cole P. J., Molyneux M. E. Lymphocyte reactivity to influenza virus in man. Immunology. 1975 Oct;29(4):749–754. [PMC free article] [PubMed] [Google Scholar]
  4. DAVENPORT F. M., HENNESSY A. V., FRANCIS T., Jr Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med. 1953 Dec;98(6):641–656. doi: 10.1084/jem.98.6.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denman E. J., Denman A. M., Greenwood B. M., Gall D., Heath R. B. Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis. 1970 May;29(3):220–231. doi: 10.1136/ard.29.3.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dolin R., Reichman R. C., Fauci A. S. Lymphocyte populations in acute viral gastroenteritis. Infect Immun. 1976 Aug;14(2):422–428. doi: 10.1128/iai.14.2.422-428.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dolin R., Richman D. D., Murphy B. R., Fauci A. S. Cell-mediated immune responses in humans after induced infection with influenza A virus. J Infect Dis. 1977 May;135(5):714–719. doi: 10.1093/infdis/135.5.714. [DOI] [PubMed] [Google Scholar]
  8. Dowdle W. R., Coleman M. T., Gregg M. B. Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol. 1974;17(0):91–135. [PubMed] [Google Scholar]
  9. Edmondson W. P., Jr, Rothenberg R., White P. W., Gwaltney J. M., Jr A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol. 1971 Jun;93(6):480–486. doi: 10.1093/oxfordjournals.aje.a121282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fauci A. S., Dale D. C. Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest. 1975 Jan;55(1):22–32. doi: 10.1172/JCI107914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gerhard W. The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin. J Exp Med. 1976 Oct 1;144(4):985–995. doi: 10.1084/jem.144.4.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Glasgow L. A. Cellular immunity in host resistance to viral infections. Arch Intern Med. 1970 Jul;126(1):125–134. [PubMed] [Google Scholar]
  13. Kantzler G. B., Lauteria S. F., Cusumano C. L., Lee J. D., Ganguly R., Waldman R. H. Immunosuppression during influenza virus infection. Infect Immun. 1974 Nov;10(5):996–1002. doi: 10.1128/iai.10.5.996-1002.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kauffman C. A., Linnemann C. C., Jr, Schiff G. M., Phair J. P. Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun. 1976 Jan;13(1):78–83. doi: 10.1128/iai.13.1.78-83.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kauffman C. A., Linnemann C. C., Jr, Tan J. S., Schiff G. M., Phair J. P. Cell-mediated immunity in humans during viral infection: dermal hypersensitivity and in vitro lymphocyte proliferation during mild viral respiratory infections. Infect Immun. 1974 Oct;10(4):757–761. doi: 10.1128/iai.10.4.757-761.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Laver W. G., Webster R. G. Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine. Virology. 1976 Feb;69(2):511–522. doi: 10.1016/0042-6822(76)90481-5. [DOI] [PubMed] [Google Scholar]
  17. Mogabgab W. J., Leiderman E. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. JAMA. 1970 Mar 9;211(10):1672–1676. [PubMed] [Google Scholar]
  18. Reed W. P., Olds J. W., Kisch A. L. Decreased skin-test reactivity associated with influenza. J Infect Dis. 1972 Apr;125(4):398–402. doi: 10.1093/infdis/125.4.398. [DOI] [PubMed] [Google Scholar]
  19. Ruben F. L., Jackson G. G., Gotoff S. P. Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun. 1973 Apr;7(4):594–596. doi: 10.1128/iai.7.4.594-596.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scheinberg M., Blacklow N. R., Goldstein A. L., Parrino T. A., Rose F. B., Cathcart E. S. Influenza: response of T-cell lymphopenia to thymosin. N Engl J Med. 1976 May 27;294(22):1208–1211. doi: 10.1056/NEJM197605272942204. [DOI] [PubMed] [Google Scholar]
  21. Schoenbaum S. C., Mostow S. R., Dowdle W. R., Coleman M. T., Kaye H. S. Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ. 1969;41(3):531–535. [PMC free article] [PubMed] [Google Scholar]
  22. Skehel J. J., Waterfield M. D. Studies on the primary structure of the influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1975 Jan;72(1):93–97. doi: 10.1073/pnas.72.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Van Kirk J. E., Mills J., Chanock R. M. Evaluation of low temperature grown influenza A2-Hong Kong virus in volunteers. Proc Soc Exp Biol Med. 1971 Jan;136(1):34–41. doi: 10.3181/00379727-136-35187. [DOI] [PubMed] [Google Scholar]
  24. Waldman R. H., Mann J. J., Small P. A., Jr Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine. JAMA. 1969 Jan 20;207(3):520–524. doi: 10.1001/jama.207.3.520. [DOI] [PubMed] [Google Scholar]
  25. Webster R. G. Antigenic hybrids of influenza A viruses with surface antigens to order. Virology. 1970 Nov;42(3):633–642. doi: 10.1016/0042-6822(70)90309-0. [DOI] [PubMed] [Google Scholar]
  26. Wheelock E. F., Toy S. T. Participation of lymphocytes in viral infections. Adv Immunol. 1973;16:123–184. doi: 10.1016/s0065-2776(08)60297-7. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES